FHOFX
Price
$28.06
Change
+$0.36 (+1.30%)
Updated
Aug 6 closing price
Net Assets
2.07B
GFACX
Price
$71.52
Change
+$0.63 (+0.89%)
Updated
Aug 6 closing price
Net Assets
322.41B
Interact to see
Advertisement

FHOFX vs GFACX

Header iconFHOFX vs GFACX Comparison
Open Charts FHOFX vs GFACXBanner chart's image
Fidelity Series Large Cp Grwth Idx
Price$28.06
Change+$0.36 (+1.30%)
VolumeN/A
Net Assets2.07B
American Funds Growth Fund of Amer C
Price$71.52
Change+$0.63 (+0.89%)
VolumeN/A
Net Assets322.41B
FHOFX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FHOFX vs. GFACX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FHOFX is a Buy and GFACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 322B vs. FHOFX (2.07B). FHOFX pays higher dividends than GFACX: FHOFX (0.49) vs GFACX (0.00). FHOFX was incepted earlier than GFACX: FHOFX (7 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than FHOFX (0.00). FHOFX is a more actively managed with annual turnover of: 28.00 vs. GFACX (25.00). FHOFX has a lower initial minimum investment than GFACX: FHOFX (0) vs GFACX (250). FHOFX annual gain was more profitable for investors over the last year : 30.73 vs. GFACX (18.41). FHOFX return over 5 years is better than : 107.94 vs. GFACX (33.13).
FHOFXGFACXFHOFX / GFACX
Total Expense Ratio0.001.36-
Annual Report Gross Expense Ratio0.001.36-
Fund Existence7 years24 years-
Gain YTD9.20312.17176%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.07B322B1%
Annual Yield % from dividends0.490.00-
Returns for 1 year30.7318.41167%
Returns for 3 years80.1239.63202%
Returns for 5 years107.9433.13326%
Returns for 10 yearsN/A67.85-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPRO2.260.14
+6.60%
Spero Therapeutics
UXIN3.830.11
+2.96%
Uxin Limited
CCRN13.100.26
+2.02%
Cross Country Healthcare
GBDC14.78-0.01
-0.07%
Golub Capital BDC
CRBG34.23-0.07
-0.20%
Corebridge Financial